Results 71 to 80 of about 2,403,288 (173)
Lineage switch in childhood leukemia
Abstract Lineage switch (LS) is a rare but aggressive immunophenotypic transformation of acute leukemia associated with limited therapeutic options and poor clinical outcome. Although LS has been increasingly recognized in the era of CD19‐directed immunotherapies, its biological basis remains incompletely understood.
Katharina Daugs +3 more
wiley +1 more source
Expression of cell cycle regulatory genes in chronic myelogenous leukemia
BACKGROUND AND OBJECTIVE: Cell cycle regulatory genes are frequently altered in a variety of malignancies. The structure and pattern of expression of eight genes involved in cell division cycle control were studied in leukemic cell samples prepared from ...
A Iolascon +5 more
doaj
Chloroma of the testis in a patient with a history of acute myeloid leukemia
Chloroma, or granulocytic sarcoma, is a rare extramedullary solid hematologic cancer, found concomitant with acute myeloid leukemia. It is infrequently associated with other myeloproliferative disorders or chronic myelogenous leukemia.
Mohammad Hossein Sanei, Matin Shariati
doaj +1 more source
Abstract figure legend Downregulation of mitotically associated long non‐coding RNA (MANCR) disturbs transcriptome and proteome in endothelial cells, possibly leading to endothelial and vascular dysfunction in preeclampsia. Abstract Preeclampsia (PE) is a hypertensive disorder during pregnancy, which is characterized by a wide spectrum of endothelial ...
Si‐Yan Zhang, Chi Zhou, Jing Zheng
wiley +1 more source
A mathematical model of chronic myelogenous leukemia [PDF]
Chronic Myelogenous Leukemia (CML) is one of the most common types of leukemia. It is characterized by a chronic, seemingly stable steady state, which gives rise to oscillatory instability in the hematapoietic stem cell count.
core
Chronic myeloid leukemia stem cells are not dependent on Bcr-Abl kinase activity for their survival [PDF]
Recent evidence suggests CML stem cells are insensitive to kinase inhibitors and responsible for minimal residual disease in treated patients. We investigated whether CML stem cells, in a transgenic mouse model of CML-like disease or derived from ...
Allan, Elaine K. +18 more
core +1 more source
Supplementary Data from A Bead-Based Activity Screen for Small-Molecule Inhibitors of Signal Transduction in Chronic Myelogenous Leukemia ...
Stephen J. Kron (2108671) +1 more
core +1 more source
Parkinsonism associated with interferon alpha therapy for chronic myelogenous leukemia. [PDF]
A 79 year-old man was treated with Interferon alpha for chronic myelogenous leukemia and developed severe parkinsonism that resolved after Interferon alpha was stopped. Carbidopa-levodopa was associated with early improvement, but discontinuation did not
Kaku, David A +2 more
core +1 more source
Sudden unilateral visual loss as an initial presentation of chronic myelogenous leukemia
Len V Hua, Salisa K WilliamsPacific University Eye Clinic, Forest Grove, OR, USAAbstract: Leukemia is a cancer of the white blood cells. Many patients with leukemia are unaware of their disease until routine blood work up for other conditions ...
Len V Hua, Salisa K Williams
doaj
Liver Gross Specimens: Chronic Myelogenous Leukemia
Liver Gross Specimens. Chronic myelogenous leukemia with myelofibrosis (of bone marrow)--chronic lymphocytic leukemia usually results in more striking hepatomegaly than CML but this liver is most remarkably enlarged, although no nodular leukemic ...
MUSC Department of Pathology and Laboratory Medicine
core

